NHMRC Clinical Trials and Cohorts Studies Grants
|Status||NHMRC HAS MOVED THE CLOSING DATES TILL NOVEMBER, SEE BELOW FOR NEW DATES|
Please note this application will be submitted via the NHMRC's new Grant Management System Sapphire. If you had an active RGMS account your CV and Profile email was migrated into Sapphire on 12 February 2020. To login to Sapphire:
1. If you have an existing RGMS account, a Sapphire account has been created for you. Click here to Activate your account.
Tutorial and training modules for Sapphire can be found here.
The objective of the Clinical Trials and Cohort Studies Grants 2019 opportunity is to support high quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
This grant opportunity is open to research proposals for clinical trials and/or cohort studies of any size – that is, they may be large or small clinical trials or cohort studies.
Please note that the Clinical Trials and Cohort Studies Grants scheme is not intended to provide ongoing support from NHMRC and grant funding does not support infrastructure costs.
Grantees will be required to report against milestones at twelve-month intervals. The desired outcomes of the Clinical Trials and Cohort Studies Grant opportunity are improvements in health and well-being, health care practice or policy, as a result of:
A Clinical Trials and Cohorts Studies Grants can be requested for between one and five years depending on the proposal.
Applications for Clinical Trials and Cohort Studies Grants are assessed by peers on the extent to which the application meets the scheme objectives. Applications will be assessed against the assessment criteria listed below. In addressing the assessment criteria, applicants should consider how the proposal addresses the associated points.
1. Significance (40%)
Significance for this grant opportunity is the extent to which the research findings will substantially advance knowledge to improve the prevention, diagnosis or treatment of medical conditions, or to improve health and wellbeing.
2. Research quality (40%)
Research quality for this grant opportunity encompasses the quality and feasibility of the proposed research, incorporating theoretical concepts, hypothesis, research design and robustness.
3. Team quality and capability (20%)
This criterion is used to assess whether the CI team named in your application has the appropriate mix of research skills and experience to undertake the clinical trial and/or cohort study and achieve the stated objectives of the proposed research.
Applications are assessed relative to opportunity, taking into consideration any career disruptions and recognising applicants’ industry-relevant expertise, where applicable
It is recognised that Aboriginal and Torres Strait Islander applicants often make additional valuable contributions to policy development, clinical/public health leadership and/or service delivery, community activities and linkages, and are often representatives on key committees. If applicable, these contributions will be considered when assessing research output and track record.
The provisional funding allocation for the Clinical Trials and Cohort Studies Grants 2019 opportunity is estimated to be up to $70 million. NHMRC’s Research Committee annually reviews and recommends indicative budget amounts to be awarded across individual funding schemes.
The amount of funding for a Clinical Trials and Cohort Studies Grant will be based on assessment of the requested budget. Applications must clearly justify the requested duration and budget, and how they will support the proposed outcomes of the research. Peer reviewers will consider this information and may reduce the duration and/or budget to ensure the research aims and objectives can be achieved while ensuring value with money.
The Faculties have their own approval and review processes for grants under this scheme. They may also have deadlines for submission of draft applications that are earlier than Research Services deadlines. Please ensure that you contact your Faculty, as early as possible, for information on process and deadlines. Faculty contacts:
Faculty of Arts
Macquarie Business School
Faculty of Medicine, Health and Human Sciences
Faculty of Science and Engineering
Changes to Eligibility for DVCR Co-Funding
Eligibility for the DVCR Co-Funding Scheme is now contingent upon on-time submission of grant applications by the Macquarie University submission date. Many applications for external funding require cash and in-kind contributions from the host institution in order to be considered for funding. In most cases, researchers request cash contributions, such as project support funds, funding for research associates, scholarships and major equipment, from the DVCR via the DVCR Co-Funding Scheme to support their external funding applications. To be eligible to request this DVCR Co-Funding, grant applications must be submitted internally, via Pure, by the Macquarie University submission date.
Dates for the 2021 Funding Round
NHMRC opening date in Sapphire: Wednesday 4 March 2020
Note: NHMRC locates all their Scheme documentation in GrantConnect. You will be required to set-up a username and password to access.
Notification Of Intent (NOI)
CERTIFICATIONSThese are built into Sapphire. No need to have separate certifications from CI's and AI's.
Introduction to the NHMRC Clinical Trials and Cohorts Studies (CTCS) Grant Funding Scheme
NHMRC Clinical Trials and Cohorts Studies (CTCS) Grant Funding Scheme
Building your Budget for the NHMRC Clinical Trials and Cohorts Studies (CTCS) Grant and Ideas Grant Schemes
|Contacts||Information and Compliance|
Research Proposals Team
Ph: +61 2 9850 4193
Ms Courtney Bendall
Research Development Manager
Ph: +61 2 9850 4745